Burak Eric 4
4 · Fusion Pharmaceuticals Inc. · Filed Feb 3, 2022
Insider Transaction Report
Form 4
Burak Eric
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-01+168,200→ 168,200 totalExercise: $7.70Exp: 2032-02-01→ Common Stock (168,200 underlying)
Footnotes (1)
- [F1]This option vests in 48 equal monthly installments beginning on March 1, 2022.